hope rugo, md, provides perspective on the clinical progress of cdk 4/6 inhibitors in breast cancer
Published 3 years ago • 98 plays • Length 4:50Download video MP4
Download video MP3
Similar videos
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
3:33
cdk 4/6 inhibitors in metastatic breast cancer
-
1:53
dr. hope rugo examines angiogenesis inhibition for advanced breast cancer
-
9:18
clinical experience: cdk4/6 inhibitors in breast cancer
-
1:22
dr. rugo on resistance to cdk4/6 inhibitors in hr breast cancer
-
3:31
hope rugo, md, examines data from the destiny-breast01 clinical study presented at sabcs 2020
-
58:22
adjuvant cdk4 and 6 inhibition to prevent recurrences in high-risk hr /her2- early breast cancer
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
3:21
comment fonctionne un inhibiteur cdk4/6 ?
-
8:55
cdk4/6 inhibitors in hr metastatic breast cancer
-
6:28
cdk4/6 inhibitors: managing toxicity in hr mbc
-
1:42
hope rugo, md, offers key takeaways for physicians regarding keynote-355
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
4:54
hope rugo, md, shares the design and outcomes of keynote-355 presented at sabcs 2020
-
22:21
“key breakthroughs in the field of breast cancer treatment” by dr. hope rugo
-
1:15
dr. rugo discusses the future of angiogenesis in breast cancer
-
1:06
priya rastogi, md, considers the interchangeability of cdk 4/6 inhibitors
-
8:28
cdk4/6 inhibition in breast cancer
-
10:09
hope rugo, md: advances and challenges in the treatment of metastatic breast cancer
-
5:31
efficacy of cdk4/6 inhibitors in hr mbc
-
54:23
role of cdk inhibitors in the treatment of advanced breast cancer
-
2:24
differentiating factors of abemaciclib among the cdk 4/6 inhibitors for breast cancer